Olokizumab Proves Noninferior to Adalimumab for RA Olokizumab Proves Noninferior to Adalimumab for RA

The manufacturer of olokizumab is expected to file for approval in the United States early next year, and the drug could add a new option for patients for whom methotrexate alone doesn ' t work.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news